Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.
about
Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strainsRedox mechanisms in hepatic chronic wound healing and fibrogenesisOmega-3 fatty acids for the treatment of non-alcoholic fatty liver diseaseDevelopment of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end productsA metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- miceNonalcoholic fatty liver disease and vascular disease: state-of-the-art.Nonalcoholic fatty liver disease - A multisystem disease?Sustained proliferation in cancer: Mechanisms and novel therapeutic targetsDifference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in miceLipotoxic effect of p21 on free fatty acid-induced steatosis in L02 cellsEnvironmental pollution: a tangible risk for NAFLD pathogenesisMicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.Ceramide-mediated insulin resistance and impairment of cognitive-motor functionsLongitudinal evaluation of hepatic lipid deposition and composition in ob/ob and ob/+ control mice.Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease.Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology.Fast food diet with CCl4 micro-dose induced hepatic-fibrosis--a novel animal model.Enhanced amelioration of high-fat diet-induced fatty liver by docosahexaenoic acid and lysine supplementationsInhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilizationRedox control of liver function in health and diseaseNonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.Nonalcoholic fatty liver disease and polycystic ovary syndrome.Experimental models of non-alcoholic fatty liver disease in rats.High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism.Coffee, alcohol and other beverages in relation to cirrhosis mortality: the Singapore Chinese Health Study.Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis.Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease.Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetesGlycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis.Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease.The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis.Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice.Curcumin limits the fibrogenic evolution of experimental steatohepatitis.Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice.CCR2 and CD44 promote inflammatory cell recruitment during fatty liver formation in a lithogenic diet fed mouse model.Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet.Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players.Specific inhibition of the redox activity of ape1/ref-1 by e3330 blocks tnf-α-induced activation of IL-8 production in liver cancer cell linesEffects of ferulic acid and γ-oryzanol on high-fat and high-fructose diet-induced metabolic syndrome in rats.
P2860
Q21559453-59B79F4B-61EC-4449-AA5D-5C42FD066905Q24656684-297FB00E-8A32-4256-9A96-ABC0582E9194Q26825517-C2CDDBB7-E828-475D-95A3-220192835F66Q26861308-51FB3A8A-147A-4985-B8EA-3EA3E4AA2629Q27339224-2853AD89-FE61-485B-A6B1-33202A4021D9Q27692035-FF54019D-066F-48E3-94A1-CA59F2410AB8Q28079077-6A5C3881-7B39-4388-8A1D-DDB564407F46Q28396388-824646BF-4580-4D9D-B900-4DF89C45123CQ28507402-0F7703F1-8401-45FA-BE39-84121D3D9CDDQ28538284-72F25C74-C6DA-498B-AA4F-14FA64A3D7D2Q28661241-93B4B524-6CA1-46F2-BB16-E10265C3E675Q30439971-CDC2FE83-0300-4852-B345-08A6FF382019Q30478907-1BBF0A3A-E874-4A29-9A5E-A3681F3EABE5Q30586373-F23121B5-688C-43AD-B6AE-B5798F000F24Q31149434-9421CA12-6A39-4DBC-90E4-9FB77349DC23Q33509626-A82C0D59-CCAC-4428-89FB-FBBD15ADAD24Q33675416-1A338E5A-3E57-4262-ABD0-4547BADD2E33Q33748530-6A6A18F2-80F1-445A-9121-6273D9D91FC5Q33824907-21760039-85CB-41B8-A9BB-A09B889A608BQ33830140-018F36AD-AFEF-456E-A697-51C5FAA62EA1Q33855157-A324A4EF-02AC-4319-87D2-2172788C4CF8Q33886930-40A8C8E4-B832-4D17-9CB3-54AF9CE2F6FCQ33886936-6C645864-5427-49B5-A4CF-9973F089FDBFQ33896110-F51ED3D5-2B8A-4DA1-A838-EC9A9E2899C2Q33946576-CB1F8E79-3D11-48C8-9403-94B6BAA22FD1Q34023427-032CD644-FB20-4CEA-8003-58BD06E2CBD6Q34103693-095BF657-AC93-4BF3-9041-84137FA712F2Q34180476-61965ED7-4D93-4E71-8C8E-217913095536Q34185998-FE26126B-B97E-4FE2-9188-5AA97BAECCDBQ34241720-1B2FC0BF-27C5-4145-8BED-CA8105AD1550Q34359482-3027D535-F9C9-4B28-A5E3-E25FD19D82EAQ34389714-B200B408-3466-4A19-B231-73333F1674FAQ34533851-883066AD-4EB7-4C85-A6E6-5BAE90823C73Q34613675-0B704625-80E8-4BB6-B457-57CD56888389Q34643771-8942E6C6-80B7-496A-8CF7-261E396F3AAAQ34769732-B468E0CF-24BE-42A9-88E9-E657305C8068Q34796362-FF5BDB51-791E-4F26-8901-0B019F7546DDQ34821020-4B5BEF68-C5EE-4CEC-A28E-4189141CDAB5Q34963206-75B6ED65-E97A-49E4-8263-4EB4B4AB84C6Q35043473-8B8D6B0F-579E-42ED-8B0C-39BF3F268846
P2860
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.
@en
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.
@nl
type
label
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.
@en
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.
@nl
prefLabel
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.
@en
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.
@nl
P50
P1476
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
@en
P2093
Gianluca Svegliati Baroni
P356
10.1016/J.MOLMED.2007.12.003
P577
2008-01-22T00:00:00Z